(Q35569854)

English

An increased osteoprotegerin serum release characterizes the early onset of diabetes mellitus and may contribute to endothelial cell dysfunction

scientific article published on December 2006

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

8 August 2017

An increased osteoprotegerin serum release characterizes the early onset of diabetes mellitus and may contribute to endothelial cell dysfunction (English)

1 reference

Europe PubMed Central

8 August 2017

0 references

Assunta Pandolfi

object named as

Assunta Pandolfi

3

0 references

object named as

Bruno Fabris

6

0 references

Silvano Capitani

object named as

Silvano Capitani

8

0 references

object named as

Giorgio Zauli

9

0 references

Paola Secchiero

object named as

Paola Secchiero

1

0 references

Federica Corallini

2

object named as

Federica Corallini

1 reference

Europe PubMed Central

8 August 2017

Claudio Celeghini

7

object named as

Claudio Celeghini

1 reference

Europe PubMed Central

8 August 2017

Riccardo Candido

5

object named as

Riccardo Candido

1 reference

Europe PubMed Central

8 August 2017

author name string

Agostino Consoli

4

1 reference

Europe PubMed Central

8 August 2017

language of work or name

0 references

publication date

1 December 2006

1 reference

Europe PubMed Central

8 August 2017

The American Journal of Pathology

1 reference

Europe PubMed Central

8 August 2017

169

1 reference

Europe PubMed Central

8 August 2017

6

1 reference

Europe PubMed Central

8 August 2017

2236-2244

1 reference

Europe PubMed Central

8 August 2017

describes a project that uses

1 reference

Europe PubMed Central

11 June 2022

https://www.ebi.ac.uk/europepmc/webservices/rest/PMC1762477/fullTextXML

based on heuristic

inferred from PubMed Central ID database lookup

Endothelial inflammation in insulin resistance

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1762477

12 July 2018

Regulation of vascular calcification by osteoclast regulatory factors RANKL and osteoprotegerin

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1762477

12 July 2018

Endothelial function: a critical determinant in atherosclerosis?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1762477

12 July 2018

Nonsteroidal anti-inflammatory drugs prevent early diabetic retinopathy via TNF-alpha suppression

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1762477

12 July 2018

RANK is essential for osteoclast and lymph node development

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1762477

12 July 2018

TRANCE is a TNF family member that regulates dendritic cell and osteoclast function

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1762477

12 July 2018

Tumor necrosis factor receptor family member RANK mediates osteoclast differentiation and activation induced by osteoprotegerin ligand

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1762477

12 July 2018

OPGL is a key regulator of osteoclastogenesis, lymphocyte development and lymph-node organogenesis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1762477

12 July 2018

Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1762477

12 July 2018

A homologue of the TNF receptor and its ligand enhance T-cell growth and dendritic-cell function

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1762477

12 July 2018

Plasma osteoprotegerin levels are associated with glycaemic status, systolic blood pressure, kidney function and cardiovascular morbidity in type 1 diabetic patients

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1762477

26 September 2018

Osteoprotegerin is associated with silent coronary artery disease in high-risk but asymptomatic type 2 diabetic patients.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1762477

26 September 2018

Association of osteoprotegerin with human abdominal aortic aneurysm progression

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1762477

26 September 2018

Arterial osteoprotegerin: increased amounts in diabetes and modifiable synthesis from vascular smooth muscle cells by insulin and TNF-alpha.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1762477

26 September 2018

Prognostic value of osteoprotegerin in heart failure after acute myocardial infarction

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1762477

26 September 2018

A stable prostacyclin analogue reduces high serum TNF-alpha levels in diabetic patients

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1762477

26 September 2018

Irbesartan but not amlodipine suppresses diabetes-associated atherosclerosis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1762477

26 September 2018

RANKL regulates endothelial cell survival through the phosphatidylinositol 3′‐kinase/Akt signal transduction pathway

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1762477

26 September 2018

Vascular endothelial growth factor up-regulates expression of receptor activator of NF-kappa B (RANK) in endothelial cells. Concomitant increase of angiogenic responses to RANK ligand

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1762477

26 September 2018

Increased plasma concentrations of osteoprotegerin in type 2 diabetic patients with microvascular complications

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1762477

26 September 2018

Activation of peroxisome proliferator-activated receptor gamma inhibits osteoprotegerin gene expression in human aortic smooth muscle cells

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1762477

26 September 2018

TNF-related activation-induced cytokine (TRANCE) induces angiogenesis through the activation of Src and phospholipase C (PLC) in human endothelial cells

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1762477

26 September 2018

Associations of serum osteoprotegerin levels with diabetes, stroke, bone density, fractures, and mortality in elderly women

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1762477

26 September 2018

Activation of the endothelial nitric-oxide synthase by tumor necrosis factor-alpha. A novel feedback mechanism regulating cell death

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1762477

26 September 2018

Osteoprotegerin serum levels in children with type 1 diabetes: a potential modulating role in bone status

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1762477

7 December 2018

Decreased endomyocardial RANKL expression in transplant coronary artery disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/17148684

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Receptor activator of NF-kappa B and osteoprotegerin expression by human microvascular endothelial cells, regulation by inflammatory cytokines, and role in human osteoclastogenesis

1 reference

https://pubmed.ncbi.nlm.nih.gov/17148684

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

PDGF induces osteoprotegerin expression in vascular smooth muscle cells by multiple signal pathways

1 reference

https://pubmed.ncbi.nlm.nih.gov/17148684

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Serum osteoprotegerin levels are associated with the presence and severity of coronary artery disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/17148684

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Increased osteoprotegerin serum levels in men with coronary artery disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/17148684

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Low serum levels of soluble RANK ligand are associated with the presence of coronary artery disease in men

1 reference

https://pubmed.ncbi.nlm.nih.gov/17148684

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Localization of osteoprotegerin, tumor necrosis factor-related apoptosis-inducing ligand, and receptor activator of nuclear factor-kappaB ligand in Mönckeberg's sclerosis and atherosclerosis

1 reference

https://pubmed.ncbi.nlm.nih.gov/17148684

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Coronary calcification in hemodialysis patients: the contribution of traditional and uremia-related risk factors

1 reference

https://pubmed.ncbi.nlm.nih.gov/17148684

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

TRAIL counteracts the proadhesive activity of inflammatory cytokines in endothelial cells by down-modulating CCL8 and CXCL10 chemokine expression and release

1 reference

https://pubmed.ncbi.nlm.nih.gov/17148684

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The relationship between plasma osteoprotegerin levels and coronary artery calcification in uncomplicated type 2 diabetic subjects

1 reference

https://pubmed.ncbi.nlm.nih.gov/17148684

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.2353/AJPATH.2006.060398

1 reference

Europe PubMed Central

8 August 2017

1 reference

Europe PubMed Central

8 August 2017

1 reference

Europe PubMed Central

8 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q35569854&oldid=1752873339"